在2019冠状病毒病大流行期间解决疫苗不公平问题:trips知识产权豁免提案及其他

IF 1.5 2区社会学 Q1 LAW

Cambridge Law Journal Pub Date : 2022-06-16 DOI:10.1017/S0008197322000241

S. Thambisetty, Aisling McMahon, Luke McDonagh, Hyo Yoon Kang, G. Dutfield

{"title":"在2019冠状病毒病大流行期间解决疫苗不公平问题:trips知识产权豁免提案及其他","authors":"S. Thambisetty, Aisling McMahon, Luke McDonagh, Hyo Yoon Kang, G. Dutfield","doi":"10.1017/S0008197322000241","DOIUrl":null,"url":null,"abstract":"Abstract This article examines global vaccine inequity during the COVID-19 pandemic. We critique intellectual property (IP) law under the 1994 WTO TRIPS Agreement, and specifically, the role that IP has played in enabling the inequities of production, distribution and pricing in the COVID-19 vaccine context. Given the failure of international response mechanisms, including COVAX and C-TAP, to address vaccine inequity, we argue the TRIPS waiver proposal should be viewed as offering a necessary and proportionate legal measure for clearing IP barriers that cannot be achieved by existing TRIPS flexibilities. Finally, we reflect on the waiver debate in the wider context of TRIPS and the need to boost global pandemic preparedness.","PeriodicalId":46389,"journal":{"name":"Cambridge Law Journal","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2022-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"ADDRESSING VACCINE INEQUITY DURING THE COVID-19 PANDEMIC: THE TRIPS INTELLECTUAL PROPERTY WAIVER PROPOSAL AND BEYOND\",\"authors\":\"S. Thambisetty, Aisling McMahon, Luke McDonagh, Hyo Yoon Kang, G. Dutfield\",\"doi\":\"10.1017/S0008197322000241\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract This article examines global vaccine inequity during the COVID-19 pandemic. We critique intellectual property (IP) law under the 1994 WTO TRIPS Agreement, and specifically, the role that IP has played in enabling the inequities of production, distribution and pricing in the COVID-19 vaccine context. Given the failure of international response mechanisms, including COVAX and C-TAP, to address vaccine inequity, we argue the TRIPS waiver proposal should be viewed as offering a necessary and proportionate legal measure for clearing IP barriers that cannot be achieved by existing TRIPS flexibilities. Finally, we reflect on the waiver debate in the wider context of TRIPS and the need to boost global pandemic preparedness.\",\"PeriodicalId\":46389,\"journal\":{\"name\":\"Cambridge Law Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2022-06-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cambridge Law Journal\",\"FirstCategoryId\":\"90\",\"ListUrlMain\":\"https://doi.org/10.1017/S0008197322000241\",\"RegionNum\":2,\"RegionCategory\":\"社会学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"LAW\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cambridge Law Journal","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.1017/S0008197322000241","RegionNum":2,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"LAW","Score":null,"Total":0}

引用次数: 3

摘要

本文探讨了COVID-19大流行期间全球疫苗不公平现象。我们根据1994年世界贸易组织《与贸易有关的知识产权协定》对知识产权法进行批评，特别是知识产权在COVID-19疫苗生产、分销和定价方面发挥的不公平作用。鉴于国际应对机制，包括covid - 19全球疫苗获取机制和C-TAP未能解决疫苗不平等问题，我们认为，应将《与贸易有关的知识产权协议》豁免提案视为一种必要和相称的法律措施，以清除现有的《与贸易有关的知识产权协议》灵活性无法实现的知识产权障碍。最后，我们在更广泛的《与贸易有关的知识产权协定》和加强全球大流行病防备的必要性的背景下思考豁免辩论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

ADDRESSING VACCINE INEQUITY DURING THE COVID-19 PANDEMIC: THE TRIPS INTELLECTUAL PROPERTY WAIVER PROPOSAL AND BEYOND

Abstract This article examines global vaccine inequity during the COVID-19 pandemic. We critique intellectual property (IP) law under the 1994 WTO TRIPS Agreement, and specifically, the role that IP has played in enabling the inequities of production, distribution and pricing in the COVID-19 vaccine context. Given the failure of international response mechanisms, including COVAX and C-TAP, to address vaccine inequity, we argue the TRIPS waiver proposal should be viewed as offering a necessary and proportionate legal measure for clearing IP barriers that cannot be achieved by existing TRIPS flexibilities. Finally, we reflect on the waiver debate in the wider context of TRIPS and the need to boost global pandemic preparedness.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cambridge Law Journal LAW-

CiteScore

1.10

自引率

6.70%

发文量

期刊介绍： The Cambridge Law Journal publishes articles on all aspects of law. Special emphasis is placed on contemporary developments, but the journal''s range includes jurisprudence and legal history. An important feature of the journal is the Case and Comment section, in which members of the Cambridge Law Faculty and other distinguished contributors analyse recent judicial decisions, new legislation and current law reform proposals. The articles and case notes are designed to have the widest appeal to those interested in the law - whether as practitioners, students, teachers, judges or administrators - and to provide an opportunity for them to keep abreast of new ideas and the progress of legal reform. Each issue also contains an extensive section of book reviews.